showed a trendp=0.083
Early CA-AKI risk within 24 hours was notably influenced by clopidogrel (p<0.05), while ARBs showed a trend towards increased risk (p=0.083) and ticagrelor showed potential protection (p=0.076).
Early CA-AKI risk within 24 hours was notably influenced by clopidogrel (p<0.05), while ARBs showed a trend towards increased risk (p=0.083) and ticagrelor showed potential protection (p=0.076).
Furthermore, Ticagrelor showed a protective trend against early CA-AKI (p = 0.076), though this finding did not reach statistical significance.